tyrosine has been researched along with Bone Marrow Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Achmad, A; Arisaka, Y; Higuchi, T; Kim, M; Miyashita, G; Miyazaki, H; Negishi, A; Tokue, A; Tominaga, H; Tsushima, Y; Yokoo, S | 1 |
Carter, YM; Chen, H; Gamblin, TC; Kunnimalaiyaan, M; Kunnimalaiyaan, S | 1 |
2 other study(ies) available for tyrosine and Bone Marrow Neoplasms
Article | Year |
---|---|
Clinical significance of ¹⁸F-α-methyl tyrosine PET/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma: comparison with ¹⁸F-FDG PET/CT and MRI.
Topics: Aged; Aged, 80 and over; Bone Marrow Neoplasms; Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tyrosine | 2013 |
Specific glycogen synthase kinase-3 inhibition reduces neuroendocrine markers and suppresses neuroblastoma cell growth.
Topics: Antineoplastic Agents; Apoptosis; Basic Helix-Loop-Helix Transcription Factors; Biomarkers, Tumor; Bone Marrow Neoplasms; Cell Line, Tumor; Cell Proliferation; Chromogranin A; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Neuroblastoma; Phosphorylation; Thiazoles; Tyrosine; Urea | 2014 |